Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000189332 | SCV000242967 | uncertain significance | not provided | 2012-08-10 | criteria provided, single submitter | clinical testing | p.Ala292Thr (GCG>ACG):c.874 G>A in exon 10 of the SLC25A22 gene (NM_024698.4). The Ala292Thr missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The NHLBI ESP Exome Variant Project has not identified Ala292Thr in approximately 6,500 individuals of European or African American ethnicity, indicating that it is not a common benign variant in these populations. The amino acid substitution is non-conservative, as a non-polar Alanine residue is replaced by a polar Threonine residue. It alters a position in the sixth transmembrane region of the protein that is conserved across species, although a Threonine residue is present at this position in primates. Multiple in silico algorithms predict the Ala292Thr may be damaging to protein structure/function. Therefore, based on the currently available information, it is unclear whether Ala292Thr is a disease-causing mutation or a rare benign variant. The variant is found in INFANT-EPI panel(s). |
Labcorp Genetics |
RCV001235057 | SCV001407721 | uncertain significance | Early infantile epileptic encephalopathy with suppression bursts | 2022-07-19 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 292 of the SLC25A22 protein (p.Ala292Thr). This variant is present in population databases (rs369729483, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SLC25A22-related conditions. ClinVar contains an entry for this variant (Variation ID: 207173). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |